L.D.L.D.CripeL.D.L.D., K.D.K.D.MooreK.D.K.D., W.H.W.H.KaneW.H.W.H., Structure of the gene for human coagulation factor V, „Biochemistry”, 31 (15), 1992, s. 3777–3785, DOI: 10.1021/bi00130a007, PMID: 1567832(ang.).
Bruno O.B.O.VilloutreixBruno O.B.O., BjörnB.DahlbäckBjörnB., Structural investigation of the A domains of human blood coagulation factor V by molecular modeling, „Protein Science”, 7 (6), 1998, s. 1317–1325, DOI: 10.1002/pro.5560070607, PMID: 9655335, PMCID: PMC2144041(ang.).
E.E.ThorelliE.E., R.J.R.J.KaufmanR.J.R.J., B.B.DahlbäckB.B., The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V, „Journal of Biological Chemistry”, 273 (26), 1998, s. 16140–16145, DOI: 10.1074/jbc.273.26.16140, PMID: 9632668(ang.).
S.S.Macedo-RibeiroS.S., W.W.BodeW.W., R.R.HuberR.R., M.A.M.A.Quinn-AllenM.A.M.A., S.W.S.W.KimS.W.S.W., Crystal structures of the membrane-binding C2 domain of human coagulation factor V, „Nature”, 402 (6760), 1999, s. 434–439, DOI: 10.1038/46594, PMID: 10586886(ang.).
J.N.J.N.HuangJ.N.J.N., M.A.M.A.KoerperM.A.M.A., Factor V deficiency: a concise review, „Haemophilia: The Official Journal of the World Federation of Hemophilia”, 14 (6), 2008, s. 1164–1169, DOI: 10.1111/j.1365-2516.2008.01785.x, PMID: 19141156(ang.).
H.H.StormorkenH.H., The discovery of factor V: a tricky clotting factor, „Journal of Thrombosis and Haemostasis”, 1 (2), 2003, s. 206–213, DOI: 10.1046/j.1538-7836.2003.00043.x, PMID: 12871488(ang.).
PL.P.GiangrandePL.P., Six characters in search of an author: the history of the nomenclature of coagulation factors, „British Journal of Haematology”, 121 (5), 2003, s. 703–712, DOI: 10.1046/j.1365-2141.2003.04333.x, PMID: 12780784.
Irving S.I.S.WrightIrving S.I.S., The Nomenclature of Blood Clotting Factors, „Thrombosis and Haemostasis”, 07 (02), 1962, s. 381–388, DOI: 10.1055/s-0038-1655480, ISSN0340-6245 [dostęp 2020-11-29].
R.M.R.M.BertinaR.M.R.M., B.P.B.P.KoelemanB.P.B.P., T.T.KosterT.T., F.R.F.R.RosendaalF.R.F.R., R.J.R.J.DirvenR.J.R.J., Mutation in blood coagulation factor V associated with resistance to activated protein C, „Nature”, 369 (6475), 1994, s. 64–67, DOI: 10.1038/369064a0, PMID: 8164741(ang.).
M.J.M.J.HeebM.J.M.J., Y.Y.KojimaY.Y., J.J.RosingJ.J., G.G.TansG.G., J.H.J.H.GriffinJ.H.J.H., C-terminal residues 621-635 of protein S are essential for binding to factor Va, „Journal of Biological Chemistry”, 274 (51), 1999, s. 36187–36192, DOI: 10.1074/jbc.274.51.36187, PMID: 10593904(ang.).
L.D.L.D.CripeL.D.L.D., K.D.K.D.MooreK.D.K.D., W.H.W.H.KaneW.H.W.H., Structure of the gene for human coagulation factor V, „Biochemistry”, 31 (15), 1992, s. 3777–3785, DOI: 10.1021/bi00130a007, PMID: 1567832(ang.).
Bruno O.B.O.VilloutreixBruno O.B.O., BjörnB.DahlbäckBjörnB., Structural investigation of the A domains of human blood coagulation factor V by molecular modeling, „Protein Science”, 7 (6), 1998, s. 1317–1325, DOI: 10.1002/pro.5560070607, PMID: 9655335, PMCID: PMC2144041(ang.).
E.E.ThorelliE.E., R.J.R.J.KaufmanR.J.R.J., B.B.DahlbäckB.B., The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V, „Journal of Biological Chemistry”, 273 (26), 1998, s. 16140–16145, DOI: 10.1074/jbc.273.26.16140, PMID: 9632668(ang.).
S.S.Macedo-RibeiroS.S., W.W.BodeW.W., R.R.HuberR.R., M.A.M.A.Quinn-AllenM.A.M.A., S.W.S.W.KimS.W.S.W., Crystal structures of the membrane-binding C2 domain of human coagulation factor V, „Nature”, 402 (6760), 1999, s. 434–439, DOI: 10.1038/46594, PMID: 10586886(ang.).
J.N.J.N.HuangJ.N.J.N., M.A.M.A.KoerperM.A.M.A., Factor V deficiency: a concise review, „Haemophilia: The Official Journal of the World Federation of Hemophilia”, 14 (6), 2008, s. 1164–1169, DOI: 10.1111/j.1365-2516.2008.01785.x, PMID: 19141156(ang.).
H.H.StormorkenH.H., The discovery of factor V: a tricky clotting factor, „Journal of Thrombosis and Haemostasis”, 1 (2), 2003, s. 206–213, DOI: 10.1046/j.1538-7836.2003.00043.x, PMID: 12871488(ang.).
P.A.P.A.OwrenP.A.P.A., Parahaemophilia; haemorrhagic diathesis due to absence of a previously unknown clotting factor, „The Lancet”, 1 (6449), 1947, s. 446–448, PMID: 20293060(ang.).
PL.P.GiangrandePL.P., Six characters in search of an author: the history of the nomenclature of coagulation factors, „British Journal of Haematology”, 121 (5), 2003, s. 703–712, DOI: 10.1046/j.1365-2141.2003.04333.x, PMID: 12780784.
R.M.R.M.BertinaR.M.R.M., B.P.B.P.KoelemanB.P.B.P., T.T.KosterT.T., F.R.F.R.RosendaalF.R.F.R., R.J.R.J.DirvenR.J.R.J., Mutation in blood coagulation factor V associated with resistance to activated protein C, „Nature”, 369 (6475), 1994, s. 64–67, DOI: 10.1038/369064a0, PMID: 8164741(ang.).
M.J.M.J.HeebM.J.M.J., Y.Y.KojimaY.Y., J.J.RosingJ.J., G.G.TansG.G., J.H.J.H.GriffinJ.H.J.H., C-terminal residues 621-635 of protein S are essential for binding to factor Va, „Journal of Biological Chemistry”, 274 (51), 1999, s. 36187–36192, DOI: 10.1074/jbc.274.51.36187, PMID: 10593904(ang.).
M.J.M.J.HeebM.J.M.J., R.M.R.M.MestersR.M.R.M., G.G.TansG.G., J.J.RosingJ.J., J.H.J.H.GriffinJ.H.J.H., Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C, „Journal of Biological Chemistry”, 268 (4), 1993, s. 2872–2877, PMID: 8428962(ang.).